Cambridge Investment Research Advisors, Inc.

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 1419186 FAIRFIELD, IA

Position in IOVA

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$592,730

+$489,283 QoQ

Shares Held

168,869

+345.6% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Healthcare · as of Mar 31, 2026

Cambridge Investment Research Advisors, Inc. holds $50,208,596 across 75 Biotechnology names. IOVA ranks #18 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	15,955	$7,124,545
2	EXEL	Exelixis, Inc.	159,749	$6,851,634
3	NKTR	Nektar Therapeutics	56,055	$4,033,157
4	REGN	Regeneron Pharmaceuticals, Inc.	4,832	$3,733,396
5	IBRX	ImmunityBio, Inc.	284,704	$2,183,679
6	BBIO	BridgeBio Pharma, Inc.	29,059	$2,157,921
7	CRSP	CRISPR Therapeutics AG	37,992	$1,807,279
8	CORT	Corcept Therapeutics Inc	42,754	$1,723,413

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$592,730	168,869	+345.6%	Shares	Sole	2026-04-30
2025-12-31	$103,447	37,893	-31.4%	Shares	Sole	2026-02-05
2025-09-30	$119,907	55,257	+17.7%	Shares	Sole	2025-11-12
2025-06-30	$80,752	46,949	+2.3%	Shares	Sole	2025-07-31
2025-03-31	$152,770	45,877	+12.9%	Shares	Sole	2025-04-22
2024-12-31	$300,736	40,640	-2.9%	Shares	Sole	2025-02-14
2024-09-30	$393,149	41,869	+15.2%	Shares	Sole	2024-10-28
2024-06-30	$291,398	36,334	+33.3%	Shares	Sole	2024-07-26
2024-03-31	$403,993	27,260	—	Shares	Sole	2024-04-24
No filing history on record for this holder in this stock.